Tennessee · 114th Regular Session (2025-2026) · Bill

HB 767: Taxes, Business - As introduced, exempts from business tax, receipts from the sale of a prescription drug or medicine with a cost for a 30-day equivalent supply that exceeds the medicare cost threshold for 2025 plan years and services necessary for proper preparation, storage, handling, administration, patient education, or post-sale monitoring of such exempted drugs or medicines. - Amends TCA Title 67, Chapter 4, Part 7.

In committee Last action April 15, 2026: Taken off notice for cal in s/c Finance, Ways and Means Subcommittee of Finance, Ways and Means Committee

Plain-language summary

HB 767 is a bill introduced in the Tennessee House on February 4, 2025. According to its official title, it concerns: Taxes, Business - As introduced, exempts from business tax, receipts from the sale of a prescription drug or medicine with a cost for a 30-day equivalent supply that exceeds the medicare cost threshold for 2025 plan years and services necessary for proper preparation, storage, handling, administration, patient education, or post-sale monitoring of such exempted drugs or medicines. - Amends TCA Title 67, Chapter 4, Part 7. Primary sponsor: Gary Hicks (Republican). Most recent recorded action (April 15, 2026): Taken off notice for cal in s/c Finance, Ways and Means Subcommittee of Finance, Ways and Means Committee.

Sponsors

Primary sponsor: Gary Hicks (Republican).